With you. And look at Compass Pathways with PPS in the $50’s. Stock markets today aren’t based on business fundamentals as in the past. More on rumor, innuendo, speculation much like a Vegas wager But regardless
Dont forget to mention GW Pharms made its run on one product alone and not much in the pipeline. Comparing that to Mindmed would be difficult since MindMed has about 3 seperate drugs (psilocybin, lsd, ibogaine) in its pipeline for future study and trials. GW on has one, cannabinoids.